Results 251 to 260 of about 3,096,858 (303)

Safety evaluation of an extension of use of the food enzyme leucyl aminopeptidase from the genetically modified <i>Aspergillus oryzae</i> strain NZYM-BU. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Solano MLM, Van Loveren H, Vernis L, Bonino I, Cavanna D, Liu Y.   +15 more
europepmc   +1 more source

Case Report: Left ventricular hemorrhage associated with early neonatal mortality in multi-gene engineered cloned pigs. [PDF]

Front Vet Sci
Kim DH, Kim DE, Kim B, Hwang IS, Sok G, Hwang S, Lee J.   +6 more
europepmc   +1 more source

Safety evaluation of a food enzyme containing carboxypeptidase C, oryzin and leucyl aminopeptidase activities from the non-genetically modified <i>Aspergillus</i> sp. strain FP 12-385. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Solano MLM, Van Loveren H, Vernis L, Andreoli C, Terron A, Yurkov A, Cavanna D, Aguilera J, Andryszkiewicz M, Kovalkovicova N, Peluso S, Liu Y.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Genetically modified animals and immunodeficiency

Current Opinion in Immunology, 1993
Mouse strains with defined genetic defects engineered by the method of targeted gene disruption and homologous recombination have furthered our understanding of immune functions at the single gene level. More importantly, these mutant 'gene knockout' mice are powerful in vivo tools to dissect the complex mechanisms of lymphocyte development and ...
R S, Yeung, J, Penninger, T W, Mak
openaire   +2 more sources